Fresenius Kabi SwissBioSim GmbH
10 clinical trials · Sponsor
◉ Watch Fresenius Kabi SwissBioSim GmbH
| Record | Firm | Date |
|---|---|---|
| Real World Use of Tocilizumab Biosimilar studY (NCT06247722) | Fresenius Kabi SwissBioSim GmbH | 2024-03-05 |
| A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis (NCT04934072) | Fresenius Kabi SwissBioSim GmbH | 2021-06-16 |
| MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis (NCT04512001) | Fresenius Kabi SwissBioSim GmbH | 2020-08-03 |
| Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS (NCT04018599) | Fresenius Kabi SwissBioSim GmbH | 2019-07-15 |
| Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456 (NCT03282851) | Fresenius Kabi SwissBioSim GmbH | 2017-11-27 |
Track Fresenius Kabi SwissBioSim GmbH automatically
Every clearance here is in the API, with alerts when new ones post.